ANON. (2000):
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
Eur. Heart J. 21, 1502-1513
ABBATE, A., R. BUSSANI, G. G. BIONDI-ZOCCAI, R. ROSSIELLO, F. SILVESTRI, F.
BALDI, L. M. BIASUCCI, A. BALDI (2002):
Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction.
Circulation 106, 1051-1054
AIKAWA, R., T. NAGAI, M. TANAKA, Y. ZOU, T. ISHIHARA, H. TAKANO, H.
HASEGAWA, H. AKAZAWA, M. MIZUKAMI, R. NAGAI, I. KOMURO (2001):
Reactive oxygen species in mechanical stress-induced cardiac hypertrophy.
Biochem. Biophys. Res. Commun. 289, 901-907
AKIYAMA, K., T. L. GLUCKMAN, A. TERHAKOPIAN, P. M. JINADASA, S.
NARAYAN, S. SINGASWAMY, B. MASSEY, 3RD, R. J. BING (1997):
Apoptosis in experimental myocardial infarction in situ and in the perfused heart in vitro.
Tissue Cell 29, 733-743
ANVERSA, P., P. LI, X. ZHANG, G. OLIVETTI, J. M. CAPASSO (1993):
Ischaemic myocardial injury and ventricular remodelling.
Cardiovasc. Res. 27, 145-157
ARMSTRONG, P. W., G. W. MOE, R. J. HOWARD, E. A. GRIMA, T. F. CRUZ (1994):
Structural remodelling in heart failure: gelatinase induction.
Can. J. Cardiol. 10, 214-220
ARNOLD, R. S., J. SHI, E. MURAD, A. M. WHALEN, C. Q. SUN, R. POLAVARAPU, S.
PARTHASARATHY, J. A. PETROS, J. D. LAMBETH (2001):
Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1.
Proc. Natl. Acad. Sci. U S A 98, 5550-5555 AUMAILLEY, M., B. GAYRAUD (1998):
Structure and biological activity of the extracellular matrix.
J. Mol. Med. 76, 253-265 BABIOR, B. M. (1999):
NADPH oxidase: an update.
Blood 93, 1464-1476
Literatur 109
BAIG, M. K., N. MAHON, W. J. MCKENNA, A. L. CAFORIO, R. O. BONOW, G. S.
FRANCIS, M. GHEORGHIADE (1998):
The pathophysiology of advanced heart failure.
Am. Heart J. 135, S216-230
BALDI, A., A. ABBATE, R. BUSSANI, G. PATTI, R. MELFI, A. ANGELINI, A.
DOBRINA, R. ROSSIELLO, F. SILVESTRI, F. BALDI, G. DI SCIASCIO (2002):
Apoptosis and post-infarction left ventricular remodeling.
J. Mol. Cell. Cardiol. 34, 165-174
BALSAM, L. B., T. KOFIDIS, R. C. ROBBINS (2005):
Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction.
J. Surg. Res. 124, 194-200
BAYRAKTUTAN, U., N. DRAPER, D. LANG, A. M. SHAH (1998):
Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells.
Cardiovasc. Res. 38, 256-262
BELL, R. M., A. C. CAVE, S. JOHAR, D. J. HEARSE, A. M. SHAH, M. J. SHATTOCK (2005):
Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning.
Faseb J. 19, 2037-2039
BENDALL, J. K., A. C. CAVE, C. HEYMES, N. GALL, A. M. SHAH (2002):
Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.
Circulation 105, 293-296
BLACK, F. M., S. E. PACKER, T. G. PARKER, L. H. MICHAEL, R. ROBERTS, R. J.
SCHWARTZ, M. D. SCHNEIDER (1991):
The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load.
J. Clin. Invest. 88, 1581-1588
BOGEN, D. K., S. A. RABINOWITZ, A. NEEDLEMAN, T. A. MCMAHON, W. H.
ABELMANN (1980):
An analysis of the mechanical disadvantage of myocardial infarction in the canine left ventricle.
Circ. Res. 47, 728-741 BÖHM, M. (2002):
Pathophysiologie der Herzinsuffizienz heute.
Herz 27, 75-91
BOUDREAU, N., M. J. BISSELL (1998):
Extracellular matrix signaling: integration of form and function in normal and malignant cells.
Curr. Opin. Cell. Biol. 10, 640-646
Literatur 110
BRAUNWALD, E., D. P. ZIPES, P. LIBBY (2001):
Heart Disease: A Textbook of Cardiovascular Medicine.
6. Aufl., Bd. 2, Verlag W.B. Saunders Company, Philadelphia, London 1124
BREISCH, E. A., F. C. WHITE, C. M. BLOOR (1984):
Myocardial characteristics of pressure overload hypertrophy. A structural and functional study.
Lab. Invest. 51, 333-342
BRIEST, W., B. RASSLER, A. DETEN, H. G. ZIMMER (2003):
Norepinephrine-induced cardiac hypertrophy and fibrosis are not due to mast cell degranulation.
Mol. Cell. Biochem. 252, 229-237
BRILLA, C. G., L. S. MATSUBARA, K. T. WEBER (1993):
Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
J. Mol. Cell. Cardiol. 25, 563-575 BRILLA, C. G., B. MAISCH (1994):
Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure.
Eur. Heart J. 15 Suppl D, 45-52
BYRNE, J. A., D. J. GRIEVE, J. K. BENDALL, J. M. LI, C. GOVE, J. D. LAMBETH, A. C.
CAVE, A. M. SHAH (2003 a):
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.
Circ. Res. 93, 802-805
BYRNE, J. A., D. J. GRIEVE, A. C. CAVE, A. M. SHAH (2003 b):
Oxidative stress and heart failure.
Arch. Mal. Coeur Vaiss. 96, 214-221
CANNON, R. O., 3RD, R. E. CUNNION, J. E. PARRILLO, S. T. PALMERI, E. E.
TUCKER, W. H. SCHENKE, S. E. EPSTEIN (1987):
Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain.
J. Am. Coll. Cardiol. 10, 1190-1200
CAPPOLA, T. P., D. A. KASS, G. S. NELSON, R. D. BERGER, G. O. ROSAS, Z. A.
KOBEISSI, E. MARBAN, J. M. HARE (2001):
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy.
Circulation 104, 2407-2411
Literatur 111
CASTIER, Y., R. P. BRANDES, G. LESECHE, A. TEDGUI, S. LEHOUX (2005):
p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling.
Circ. Res. 97, 533-540
CAVE, A., D. GRIEVE, S. JOHAR, M. ZHANG, A. M. SHAH (2005):
NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology.
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360, 2327-2334
CAVE, A. C., A. C. BREWER, A. NARAYANAPANICKER, R. RAY, D. J. GRIEVE, S.
WALKER, A. M. SHAH (2006):
NADPH oxidases in cardiovascular health and disease.
Antioxid. Redox Signal. 8, 691-728
CESSELLI, D., I. JAKONIUK, L. BARLUCCHI, A. P. BELTRAMI, T. H. HINTZE, B.
NADAL-GINARD, J. KAJSTURA, A. LERI, P. ANVERSA (2001):
Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy.
Circ. Res. 89, 279-286
CHENG, T. H., P. Y. CHENG, N. L. SHIH, I. B. CHEN, D. L. WANG, J. J. CHEN (2003):
Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts.
J. Am. Coll. Cardiol. 42, 1845-1854
CLARK, W. A., S. J. RUDNICK, J. J. LAPRES, L. C. ANDERSEN, M. C. LAPOINTE (1993):
Regulation of hypertrophy and atrophy in cultured adult heart cells.
Circ. Res. 73, 1163-1176
CLEUTJENS, J. P., J. C. KANDALA, E. GUARDA, R. V. GUNTAKA, K. T. WEBER (1995):
Regulation of collagen degradation in the rat myocardium after infarction.
J. Mol. Cell. Cardiol. 27, 1281-1292
COHN, J. N., R. FERRARI, N. SHARPE (2000):
Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.
J. Am. Coll. Cardiol. 35, 569-582
COMMUNAL, C., K. SINGH, D. R. PIMENTEL, W. S. COLUCCI (1998):
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway.
Circulation 98, 1329-1334
Literatur 112
CONDORELLI, G., R. RONCARATI, J. ROSS, JR., A. PISANI, G. STASSI, M. TODARO, S. TROCHA, A. DRUSCO, Y. GU, M. A. RUSSO, G. FRATI, S. P. JONES, D. J. LEFER, C.
NAPOLI, C. M. CROCE (2001):
Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function.
Proc. Natl. Acad. Sci. U S A 98, 9977-9982
CREEMERS, E. E., J. P. CLEUTJENS, J. F. SMITS, M. J. DAEMEN (2001):
Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Circ. Res. 89, 201-210
DATE, M. O., T. MORITA, N. YAMASHITA, K. NISHIDA, O. YAMAGUCHI, Y.
HIGUCHI, S. HIROTANI, Y. MATSUMURA, M. HORI, M. TADA, K. OTSU (2002):
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model.
J. Am. Coll. Cardiol. 39, 907-912
DE JONG, J. W., R. G. SCHOEMAKER, R. DE JONGE, P. BERNOCCHI, E. KEIJZER, R.
HARRISON, H. S. SHARMA, C. CECONI (2000):
Enhanced expression and activity of xanthine oxidoreductase in the failing heart.
J. Mol. Cell. Cardiol. 32, 2083-2089
DEGABRIELE, N. M., U. GRIESENBACH, K. SATO, M. J. POST, J. ZHU, J. WILLIAMS, P. K. JEFFERY, D. M. GEDDES, E. W. ALTON (2004):
Critical appraisal of the mouse model of myocardial infarction.
Exp. Physiol. 89, 497-505
DHALLA, A. K., M. F. HILL, P. K. SINGAL (1996):
Role of oxidative stress in transition of hypertrophy to heart failure.
J. Am. Coll. Cardiol. 28, 506-514
DIAZ-VELEZ, C. R., S. GARCIA-CASTINEIRAS, E. MENDOZA-RAMOS, E.
HERNANDEZ-LOPEZ (1996):
Increased malondialdehyde in peripheral blood of patients with congestive heart failure.
Am. Heart J. 131, 146-152
DIETRICH, W. F., J. MILLER, R. STEEN, M. A. MERCHANT, D. DAMRON-BOLES, Z.
HUSAIN, R. DREDGE, M. J. DALY, K. A. INGALLS, T. J. O'CONNOR (1996):
A comprehensive genetic map of the mouse genome.
Nature 380, 149-152
DIRKSEN, G., H.-D. GRÜNDER, M. STÖBER (2002):
Innere Medizin und Chirurgie des Rindes.
4. Aufl., Blackwell Verlag, Berlin, Wien 166-169
Literatur 113
DUCHARME, A., S. FRANTZ, M. AIKAWA, E. RABKIN, M. LINDSEY, L. E. ROHDE, F.
J. SCHOEN, R. A. KELLY, Z. WERB, P. LIBBY, R. T. LEE (2000):
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.
J. Clin. Invest. 106, 55-62
EKELUND, U. E., R. W. HARRISON, O. SHOKEK, R. N. THAKKAR, R. S. TUNIN, H.
SENZAKI, D. A. KASS, E. MARBAN, J. M. HARE (1999):
Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure.
Circ. Res. 85, 437-445
ENGBERDING, N., S. SPIEKERMANN, A. SCHAEFER, A. HEINEKE, A. WIENCKE, M.
MULLER, M. FUCHS, D. HILFIKER-KLEINER, B. HORNIG, H. DREXLER, U.
LANDMESSER (2004):
Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
Circulation 110, 2175-2179 ERDMANN, E. (2006):
Klinische Kardiologie.
6. Aufl., Springer Medizin Verlag, Heidelberg 36, 37, 101, 229, 238
ERLEBACHER, J. A., J. L. WEISS, L. W. EATON, C. KALLMAN, M. L. WEISFELDT, B.
H. BULKLEY (1982):
Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study.
Am. J. Cardiol. 49, 1120-1126
FLESCH, M., C. MAACK, B. CREMERS, A. T. BAUMER, M. SUDKAMP, M. BOHM (1999):
Effect of beta-blockers on free radical-induced cardiac contractile dysfunction.
Circulation 100, 346-353
FRANTZ, S., R. P. BRANDES, K. HU, K. RAMMELT, J. WOLF, H. SCHEUERMANN, G.
ERTL, J. BAUERSACHS (2006):
Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX.
Basic Res. Cardiol. 101, 127-132
FREUDIGER, U., E.-G. GRÜNBAUM, E. SCHIMKE (1997):
Klinik der Hundekrankheiten.
2. Aufl., Ferdinand Enke Verlag, Stuttgart 392-396
Literatur 114
FUCHS, M., H. DREXLER (2000):
Pathophysiologie der chronischen Herzinsuffizienz.
Internist 41, 93-104
FUKUI, T., M. YOSHIYAMA, A. HANATANI, T. OMURA, J. YOSHIKAWA, Y. ABE (2001):
Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction.
Biochem. Biophys. Res. Commun. 281, 1200-1206 GEWIES, A. (2003):
Introduction to Apoptosis.
[http://www.celldeath.de/encyclo/aporev/apointro.pdf]
GIORDANO, F. J. (2005):
Oxygen, oxidative stress, hypoxia, and heart failure.
J. Clin. Invest. 115, 500-508
GRIENDLING, K. K., D. SORESCU, M. USHIO-FUKAI (2000):
NAD(P)H oxidase: role in cardiovascular biology and disease.
Circ. Res. 86, 494-501
GRIEVE, D. J., J. A. BYRNE, A. SIVA, J. LAYLAND, S. JOHAR, A. C. CAVE, A. M.
SHAH (2006):
Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
J. Am. Coll. Cardiol. 47, 817-826
GUSTAFSSON, F., C. TORP-PEDERSEN, B. BRENDORP, M. SEIBAEK, H.
BURCHARDT, L. KOBER (2003):
Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function.
Eur. Heart J. 24, 863-870
HARBORD, M., M. NOVELLI, B. CANAS, D. POWER, C. DAVIS, J. GODOVAC-ZIMMERMANN, J. ROES, A. W. SEGAL (2002):
Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice.
J. Biol. Chem. 277, 5468-5475
HAUNSTETTER, A., S. IZUMO (1998):
Apoptosis: basic mechanisms and implications for cardiovascular disease.
Circ. Res. 82, 1111-1129
HAYAKAWA, K., G. TAKEMURA, M. KANOH, Y. LI, M. KODA, Y. KAWASE, R.
MARUYAMA, H. OKADA, S. MINATOGUCHI, T. FUJIWARA, H. FUJIWARA (2003):
Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage.
Circulation 108, 104-109
Literatur 115
HAYASHIDANI, S., H. TSUTSUI, T. SHIOMI, N. SUEMATSU, S. KINUGAWA, T. IDE, J. WEN, A. TAKESHITA (2002):
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Circulation 105, 868-873
HAYASHIDANI, S., H. TSUTSUI, M. IKEUCHI, T. SHIOMI, H. MATSUSAKA, T.
KUBOTA, K. IMANAKA-YOSHIDA, T. ITOH, A. TAKESHITA (2003):
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
Am. J. Physiol. Heart Circ. Physiol. 285, H1229-1235
HEYMANS, S., A. LUTTUN, D. NUYENS, G. THEILMEIER, E. CREEMERS, L.
MOONS, G. D. DYSPERSIN, J. P. CLEUTJENS, M. SHIPLEY, A. ANGELLILO, M. LEVI, O. NUBE, A. BAKER, E. KESHET, F. LUPU, J. M. HERBERT, J. F. SMITS, S. D.
SHAPIRO, M. BAES, M. BORGERS, D. COLLEN, M. J. DAEMEN, P. CARMELIET (1999):
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.
Nat. Med. 5, 1135-1142
HEYMES, C., J. K. BENDALL, P. RATAJCZAK, A. C. CAVE, J. L. SAMUEL, G.
HASENFUSS, A. M. SHAH (2003):
Increased myocardial NADPH oxidase activity in human heart failure.
J. Am. Coll. Cardiol. 41, 2164-2171
HO, K. K., J. L. PINSKY, W. B. KANNEL, D. LEVY (1993):
The epidemiology of heart failure: the Framingham Study.
J. Am. Coll. Cardiol. 22, 6A-13A
HOFFMEYER, M. R., S. P. JONES, C. R. ROSS, B. SHARP, M. B. GRISHAM, F. S.
LAROUX, T. J. STALKER, R. SCALIA, D. J. LEFER (2000):
Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice.
Circ. Res. 87, 812-817
HOPPE, U. C., M. BÖHM, R. DIETZ, P. HANRATH, H. K. KROEMER, A. OSTERSPEY, A. A. SCHMALTZ, E. ERDMANN (2005):
Leitlinien zur Therapie der chronischen Herzinsuffizienz.
Z. Kardiol. 94, 488-509 HORDIJK, P. L. (2006):
Regulation of NADPH oxidases: the role of Rac proteins.
Circ. Res. 98, 453-462
HUNTER, J. J., K. R. CHIEN (1999):
Signaling pathways for cardiac hypertrophy and failure.
N. Engl. J. Med. 341, 1276-1283
Literatur 116
HUTCHINS, G. M., B. H. BULKLEY (1978):
Infarct expansion versus extension: two different complications of acute myocardial infarction.
Am. J. Cardiol. 41, 1127-1132
IDE, T., H. TSUTSUI, S. KINUGAWA, N. SUEMATSU, S. HAYASHIDANI, K.
ICHIKAWA, H. UTSUMI, Y. MACHIDA, K. EGASHIRA, A. TAKESHITA (2000):
Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium.
Circ. Res. 86, 152-157
INOKUBO, Y., H. HANADA, H. ISHIZAKA, T. FUKUSHI, T. KAMADA, K. OKUMURA (2001):
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Am. Heart J. 141, 211-217
IRANI, K., Y. XIA, J. L. ZWEIER, S. J. SOLLOTT, C. J. DER, E. R. FEARON, M.
SUNDARESAN, T. FINKEL, P. J. GOLDSCHMIDT-CLERMONT (1997):
Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts.
Science 275, 1649-1652
The p47phox mouse knock-out model of chronic granulomatous disease.
J. Exp. Med. 182, 751-758
JANICKI, J. S., G. L. BROWER, J. D. GARDNER, A. L. CHANCEY, J. A. STEWART, JR.
(2004):
The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.
Heart Fail. Rev. 9, 33-42
JOHAR, S., A. C. CAVE, A. NARAYANAPANICKER, D. J. GRIEVE, A. M. SHAH (2006):
Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.
Faseb J. 20, 1546-1548
Literatur 117
JONES, R. D., J. T. HANCOCK, A. H. MORICE (2000):
NADPH oxidase: a universal oxygen sensor?
Free Radic. Biol. Med. 29, 416-424
JONES, S. A., V. B. O'DONNELL, J. D. WOOD, J. P. BROUGHTON, E. J. HUGHES, O. T.
JONES (1996):
Expression of phagocyte NADPH oxidase components in human endothelial cells.
Am. J. Physiol. 271, H1626-1634
JUGDUTT, B. I., B. L. MICHOROWSKI (1987):
Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: a two-dimensional echocardiographic study.
Clin. Cardiol. 10, 641-652
KAJSTURA, J., E. CIGOLA, A. MALHOTRA, P. LI, W. CHENG, L. G. MEGGS, P.
ANVERSA (1997):
Angiotensin II induces apoptosis of adult ventricular myocytes in vitro.
J. Mol. Cell. Cardiol. 29, 859-870
KANEKAR, S., T. HIROZANNE, L. TERRACIO, T. K. BORG (1998):
Cardiac fibroblasts: Form and function.
Cardiovasc. Pathol. 7, 127-133 KATZ, A. M. (1990):
Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.
N. Engl. J. Med. 322, 100-110
KAYE, D. M., J. LEFKOVITS, G. L. JENNINGS, P. BERGIN, A. BROUGHTON, M. D.
ESLER (1995):
Adverse consequences of high sympathetic nervous activity in the failing human heart.
J. Am. Coll. Cardiol. 26, 1257-1263
KEITH, M., A. GERANMAYEGAN, M. J. SOLE, R. KURIAN, A. ROBINSON, A. S.
OMRAN, K. N. JEEJEEBHOY (1998):
Increased oxidative stress in patients with congestive heart failure.
J. Am. Coll. Cardiol. 31, 1352-1356
KINUGAWA, S., H. TSUTSUI, S. HAYASHIDANI, T. IDE, N. SUEMATSU, S. SATOH, H. UTSUMI, A. TAKESHITA (2000):
Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress.
Circ. Res. 87, 392-398
KOGLER, H., D. G. SOERGEL, A. M. MURPHY, E. MARBAN (2001):
Maintained contractile reserve in a transgenic mouse model of myocardial stunning.
Am. J. Physiol. Heart Circ. Physiol. 280, H2623-2630
Literatur 118
KRIJNEN, P. A., C. MEISCHL, C. E. HACK, C. J. MEIJER, C. A. VISSER, D. ROOS, H.
W. NIESSEN (2003):
Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction.
J. Clin. Pathol. 56, 194-199
KUMAR, D., B. I. JUGDUTT (2003):
Apoptosis and oxidants in the heart.
J. Lab. Clin. Med. 142, 288-297
KUNSCH, C., R. M. MEDFORD (1999):
Oxidative stress as a regulator of gene expression in the vasculature.
Circ. Res. 85, 753-766
LANDMESSER, U., S. SPIEKERMANN, S. DIKALOV, H. TATGE, R. WILKE, C.
KOHLER, D. G. HARRISON, B. HORNIG, H. DREXLER (2002):
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure:
role of xanthine-oxidase and extracellular superoxide dismutase.
Circulation 106, 3073-3078
LANDMESSER, U., S. DIKALOV, S. R. PRICE, L. MCCANN, T. FUKAI, S. M.
HOLLAND, W. E. MITCH, D. G. HARRISON (2003):
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.
J. Clin. Invest. 111, 1201-1209
LASSEGUE, B., R. E. CLEMPUS (2003):
Vascular NAD(P)H oxidases: specific features, expression, and regulation.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R277-297
LATIF, N., M. A. KHAN, E. BIRKS, A. O'FARRELL, J. WESTBROOK, M. J. DUNN, M.
H. YACOUB (2000):
Upregulation of the Bcl-2 family of proteins in end stage heart failure.
J. Am. Coll. Cardiol. 35, 1769-1777 LAWEN, A. (2003):
Apoptosis-an introduction.
Bioessays 25, 888-896
LI, J. M., N. P. GALL, D. J. GRIEVE, M. CHEN, A. M. SHAH (2002 a):
Activation of NADPH oxidase during progression of cardiac hypertrophy to failure.
Hypertension 40, 477-484
LI, J. M., A. M. MULLEN, S. YUN, F. WIENTJES, G. Y. BROUNS, A. J. THRASHER, A.
M. SHAH (2002 b):
Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha.
Circ. Res. 90, 143-150
Literatur 119
LI, J. M., A. M. SHAH (2003):
Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit.
J. Biol. Chem. 278, 12094-12100 LI, J. M., A. M. SHAH (2004 a):
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R1014-1030
LI, J. M., S. WHEATCROFT, L. M. FAN, M. T. KEARNEY, A. M. SHAH (2004 b):
Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
Circulation 109, 1307-1313
LI, Q., R. BOLLI, Y. QIU, X. L. TANG, S. S. MURPHREE, B. A. FRENCH (1998):
Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits.
Circulation 98, 1438-1448
LINDSEY, M. L., J. GANNON, M. AIKAWA, F. J. SCHOEN, E. RABKIN, L. LOPRESTI-MORROW, J. CRAWFORD, S. BLACK, P. LIBBY, P. G. MITCHELL, R. T. LEE (2002):
Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.
Circulation 105, 753-758 LINDSEY, M. L. (2004):
MMP induction and inhibition in myocardial infarction.
Heart Fail. Rev. 9, 7-19 LINZBACH, A. J. (1956):
Über das Längenwachstum der Herzmuskelfasern und ihrer Kerne in Beziehung zur Herzdilatation.
Virchows Arch. 328, 165-181
LIU, Y., A. LERI, B. LI, X. WANG, W. CHENG, J. KAJSTURA, P. ANVERSA (1998):
Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes.
Circ. Res. 82, 1145-1159
LLOYD-JONES, D. M., M. G. LARSON, E. P. LEIP, A. BEISER, R. B. D'AGOSTINO, W.
B. KANNEL, J. M. MURABITO, R. S. VASAN, E. J. BENJAMIN, D. LEVY (2002):
Lifetime risk for developing congestive heart failure: the Framingham Heart Study.
Circulation 106, 3068-3072
Literatur 120
LÖSCHER, W., F. R. UNGEMACH, R. KROKER (1999):
Pharmakotherapie bei Haus- und Nutztieren.
4. Aufl., Parey Buchverlag im Blackwell Wissenschafts-Verlag, Berlin 49-51
MA, J. S., P. Y. CHEN, L. S. FU, C. S. CHI, Y. F. HUANG, C. Y. LIN, C. C. SHIEH (2000):
Chronic granulomatous disease: a case report.
J. Microbiol. Immunol. Infect. 33, 118-122
MAACK, C., T. KARTES, H. KILTER, H. J. SCHAFERS, G. NICKENIG, M. BOHM, U.
LAUFS (2003):
Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment.
Circulation 108, 1567-1574
MACCARTHY, P. A., D. J. GRIEVE, J. M. LI, C. DUNSTER, F. J. KELLY, A. M. SHAH (2001):
Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase.
Circulation 104, 2967-2974
MACLEAN, D., M. C. FISHBEIN, P. R. MAROKO, E. BRAUNWALD (1976):
Hyaluronidase-induced reductions in myocardial infarct size.
Science 194, 199-200
MACLELLAN, W. R., M. D. SCHNEIDER (1997):
Death by design. Programmed cell death in cardiovascular biology and disease.
Circ. Res. 81, 137-144
MALLAT, Z., I. PHILIP, M. LEBRET, D. CHATEL, J. MACLOUF, A. TEDGUI (1998):
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure.
Circulation 97, 1536-1539 MANN, D. L. (1999):
Mechanisms and models in heart failure: A combinatorial approach.
Circulation 100, 999-1008
MATSUMURA, S., S. IWANAGA, S. MOCHIZUKI, H. OKAMOTO, S. OGAWA, Y.
OKADA (2005):
Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
J. Clin. Invest. 115, 599-609
Literatur 121
MATSUNO, K., H. YAMADA, K. IWATA, D. JIN, M. KATSUYAMA, M. MATSUKI, S.
TAKAI, K. YAMANISHI, M. MIYAZAKI, H. MATSUBARA, C. YABE-NISHIMURA (2005):
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
Circulation 112, 2677-2685
MAYTIN, M., D. A. SIWIK, M. ITO, L. XIAO, D. B. SAWYER, R. LIAO, W. S. COLUCCI (2004):
Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox.
Circulation 109, 1168-1171
MCNALLY, J. S., M. E. DAVIS, D. P. GIDDENS, A. SAHA, J. HWANG, S. DIKALOV, H.
JO, D. G. HARRISON (2003):
Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress.
Am. J. Physiol. Heart Circ. Physiol. 285, H2290-2297
MCNALLY, J. S., A. SAXENA, H. CAI, S. DIKALOV, D. G. HARRISON (2005):
Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium.
Arterioscler. Thromb. Vasc. Biol. 25, 1623-1628
MILLANE, T., G. JACKSON, C. R. GIBBS, G. Y. LIP (2000):
ABC of heart failure. Acute and chronic management strategies.
Bmj. 320, 559-562
MURDOCH, C. E., M. ZHANG, A. C. CAVE, A. M. SHAH (2006):
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.
Cardiovasc. Res. 71, 208-215
NAKAGAMI, H., M. TAKEMOTO, J. K. LIAO (2003):
NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy.
J. Mol. Cell. Cardiol. 35, 851-859
NAKAMURA, H., H. UENO, K. YAMASHITA, T. SHIMADA, E. YAMAMOTO, M.
NOGUCHI, N. FUJIMOTO, H. SATO, M. SEIKI, Y. OKADA (1999):
Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Cancer Res. 59, 467-473
NAKAMURA, K., K. FUSHIMI, H. KOUCHI, K. MIHARA, M. MIYAZAKI, T. OHE, M.
NAMBA (1998):
Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II.
Circulation 98, 794-799
Literatur 122
NAKAMURA, R., K. EGASHIRA, Y. MACHIDA, S. HAYASHIDANI, M. TAKEYA, H.
UTSUMI, H. TSUTSUI, A. TAKESHITA (2002):
Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation.
Circulation 106, 362-367
NARULA, J., N. HAIDER, R. VIRMANI, T. G. DISALVO, F. D. KOLODGIE, R. J.
HAJJAR, U. SCHMIDT, M. J. SEMIGRAN, G. W. DEC, B. A. KHAW (1996):
Apoptosis in myocytes in end-stage heart failure.
N. Engl. J. Med. 335, 1182-1189
NARULA, J., Y. CHANDRASEKHAR, G. W. DEC (1998):
Apoptosis in heart failure: a tale of heightened expectations, unfulfilled promises and broken hearts em leader.
Apoptosis 3, 309-315
NARULA, J., P. PANDEY, E. ARBUSTINI, N. HAIDER, N. NARULA, F. D. KOLODGIE, B. DAL BELLO, M. J. SEMIGRAN, A. BIELSA-MASDEU, G. W. DEC, S. ISRAELS, M.
BALLESTER, R. VIRMANI, S. SAXENA, S. KHARBANDA (1999):
Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy.
Proc. Natl. Acad. Sci. U S A 96, 8144-8149
NAUMOVA, A. V., V. P. CHACKO, R. OUWERKERK, L. STULL, E. MARBAN, R. G.
WEISS (2006):
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts.
Am. J. Physiol. Heart Circ. Physiol. 290, H837-843
OLIVETTI, G., R. ABBI, F. QUAINI, J. KAJSTURA, W. CHENG, J. A. NITAHARA, E.
QUAINI, C. DI LORETO, C. A. BELTRAMI, S. KRAJEWSKI, J. C. REED, P. ANVERSA (1997):
Apoptosis in the failing human heart.
N. Engl. J. Med. 336, 1131-1141
PAGANO, P. J., J. K. CLARK, M. E. CIFUENTES-PAGANO, S. M. CLARK, G. M.
CALLIS, M. T. QUINN (1997):
Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II.
Proc. Natl. Acad. Sci. U S A 94, 14483-14488
PALOJOKI, E., A. SARASTE, A. ERIKSSON, K. PULKKI, M. KALLAJOKI, L. M.
VOIPIO-PULKKI, I. TIKKANEN (2001):
Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats.
Am. J. Physiol. Heart Circ. Physiol. 280, H2726-2731
Literatur 123
PARK, Y. M., M. Y. PARK, Y. L. SUH, J. B. PARK (2004):
NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats.
Biochem. Biophys. Res. Commun. 313, 812-817
PATTEN, R. D., M. J. ARONOVITZ, L. DERAS-MEJIA, N. G. PANDIAN, G. G. HANAK, J. J. SMITH, M. E. MENDELSOHN, M. A. KONSTAM (1998):
Ventricular remodeling in a mouse model of myocardial infarction.
Am. J. Physiol. 274, H1812-1820
PETERSON, J. T., H. LI, L. DILLON, J. W. BRYANT (2000):
Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Cardiovasc. Res. 46, 307-315
PETERSON, J. T., H. HALLAK, L. JOHNSON, H. LI, P. M. O'BRIEN, D. R. SLISKOVIC, T. M. BOCAN, M. L. COKER, T. ETOH, F. G. SPINALE (2001):
Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
Circulation 103, 2303-2309
PFEFFER, J. M., M. A. PFEFFER, P. J. FLETCHER, E. BRAUNWALD (1991):
Progressive ventricular remodeling in rat with myocardial infarction.
Am. J. Physiol. 260, H1406-1414
PFEFFER, M. A., E. BRAUNWALD (1990):
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
Circulation 81, 1161-1172
PIMENTEL, D. R., J. K. AMIN, L. XIAO, T. MILLER, J. VIERECK, J. OLIVER-KRASINSKI, R. BALIGA, J. WANG, D. A. SIWIK, K. SINGH, P. PAGANO, W. S.
COLUCCI, D. B. SAWYER (2001):
Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes.
Circ. Res. 89, 453-460
POLLOCK, J. D., D. A. WILLIAMS, M. A. GIFFORD, L. L. LI, X. DU, J. FISHERMAN, S.
H. ORKIN, C. M. DOERSCHUK, M. C. DINAUER (1995):
Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production.
Nat. Genet. 9, 202-209
PSCHYREMBEL, W. (2002):
Pschyrembel Klinisches Wörterbuch.
259. Aufl., Verlag Walter de Gruyter, Berlin 686-687
Literatur 124
ROHDE, L. E., A. DUCHARME, L. H. ARROYO, M. AIKAWA, G. H. SUKHOVA, A.
LOPEZ-ANAYA, K. F. MCCLURE, P. G. MITCHELL, P. LIBBY, R. T. LEE (1999):
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.
Circulation 99, 3063-3070
ROMANIC, A. M., C. L. BURNS-KURTIS, B. GOUT, I. BERREBI-BERTRAND, E. H.
OHLSTEIN (2001):
Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit.
Life Sci. 68, 799-814
SABBAH, H. N., V. G. SHAROV, R. C. GUPTA, A. TODOR, V. SINGH, S. GOLDSTEIN
SABBAH, H. N., V. G. SHAROV, R. C. GUPTA, A. TODOR, V. SINGH, S. GOLDSTEIN